-
Signature
-
/s/ Pamela Sergeeff, Attorney-in-fact
-
Issuer symbol
-
FRSH
-
Transactions as of
-
28 Jun 2023
-
Net transactions value
-
-$115,307
-
Form type
-
4
-
Filing time
-
30 Jun 2023, 17:42:21 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FRSH |
Class A Common Stock |
Conversion of derivative security |
$0 |
+6,559 |
+40% |
$0.000000 |
22,987 |
30 Jun 2023 |
Direct |
|
| transaction |
FRSH |
Class A Common Stock |
Sale |
$115,307 |
-6,559 |
-29% |
$17.58 |
16,428 |
30 Jun 2023 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FRSH |
Restricted Stock Units |
Options Exercise |
$0 |
-7,810 |
-11% |
$0.000000 |
62,500 |
28 Jun 2023 |
Class B Common Stock |
7,810 |
|
Direct |
F3, F4 |
| transaction |
FRSH |
Restricted Stock Units |
Options Exercise |
$0 |
-1,560 |
-3.7% |
$0.000000 |
40,630 |
28 Jun 2023 |
Class B Common Stock |
1,560 |
|
Direct |
F3, F5 |
| transaction |
FRSH |
Class B Common Stock |
Options Exercise |
$0 |
+9,370 |
+28% |
$0.000000 |
43,120 |
28 Jun 2023 |
Class A Common Stock |
9,370 |
|
Direct |
F6 |
| transaction |
FRSH |
Class B Common Stock |
Conversion of derivative security |
$0 |
-6,559 |
-15% |
$0.000000 |
36,561 |
30 Jun 2023 |
Class A Common Stock |
6,559 |
|
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: